Advertisement
UK markets close in 2 hours 36 minutes
  • FTSE 100

    7,865.45
    +17.46 (+0.22%)
     
  • FTSE 250

    19,378.82
    +38.68 (+0.20%)
     
  • AIM

    743.09
    -0.03 (-0.00%)
     
  • GBP/EUR

    1.1680
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2463
    +0.0007 (+0.05%)
     
  • Bitcoin GBP

    49,874.78
    -200.22 (-0.40%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CRUDE OIL

    82.52
    -0.17 (-0.21%)
     
  • GOLD FUTURES

    2,398.70
    +10.30 (+0.43%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,764.93
    -5.09 (-0.03%)
     
  • CAC 40

    8,000.81
    +19.30 (+0.24%)
     

The Pandemic May Have Saved CVS

In November, Amazon (NASDAQ: AMZN) launched its online pharmacy service, which not only allows customers to order prescriptions at a competitive price point, but also comes with the same expedited shipping Prime members are used to. Earnings per share came in at $2.04 versus Wall Street's estimated $1.72, while revenue was recorded at $69.1 billion, an improvement from the $68.39 billion analysts had expected. Early on in the pandemic, customers flocked to CVS to load up on supplies and prescriptions.